Annual Report 2022

Proposed Amendments to the Articles of Association

Removal of Stock Marker

Boan to Remove “B” Marker from Its Stock Short Name at HKEX

Boan Biotech today announced that the Hong Kong Stock Exchange (HKEX) has approved the company’s application to remove the "B" marker from its stock short name, as the company has sati...

Dis-application of Rules 18A.09 to 18A.11 of the Listing Rules

Voluntary Announcement Biologics License Application for Boyounuo Accepted in Brazil

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023

BLA for Boan's Boyounuo® (Bevacizumab) Accepted in Brazil

Boan Biotech today announced that Brazil's Agência Nacional de Vigilância Sanitária (ANVISA) has accepted the company's Biologic License Application (BLA) for Boyounuo® (Bev...

Connected Transaction Rent Sharing Agreement

Boan Biotech Announces 2022 Financial Results

Boan Biotech (6955.HK) announced its 2022 financial results and recent business developments on March 27, 2023.2022 business highlightsRecord high in revenueIn 2022, Boan Biotech's revenue was app...